Bristol-Myers Squibb News and Activities

Presence

Bristol-Myers Squibb develops and sells prescription medicines for serious diseases. Its products support patients, hospitals, and healthcare providers in areas such as cancer, blood disorders, cardiovascular conditions, and immunology.

Bristol-Myers Squibb products and services overview:

Cancer medicines
Immunology therapies
Cardiovascular drugs
Blood disorder treatments
Neuroscience medicines
Cell therapies

Revenue: ~$48 billion

Employees: 34,000

Headquarters: Princeton, United States (USA)

Bristol-Myers Squibb is one of the...

Bristol-Myers Squibb is a company listed under the stock ticker BMY (US).

Bristol-Myers Squibb has a direct presence in 20 countries.

Bristol-Myers Squibb has 20 subsidiaries including Bristol-Myers Squibb APAC, Bristol-Myers Squibb Australia and Bristol-Myers Squibb Benelux.

They are in:

Pharmaceuticals95%
Biotechnology5%

Acquisition, funding and merger involving Bristol-Myers Squibb.

Bristol-Myers Squibb has acquired Orbital Therapeutics (posted on December 12 2025).
Bristol-Myers Squibb has announced the acquisition of Orbital Therapeutics (posted on October 14 2025).
Bristol-Myers Squibb has announced the acquisition of 2Seventy Bio (posted on March 11 2025).

Executives

View the org chart displaying its 147 main executives

Most searched biographies at Bristol-Myers Squibb

Popular executive movements at Bristol-Myers Squibb

Pooja Mankani, who was Director, AI Engineering and Enablement, is promoted to Senior Director, AI Engineering and Enablement (posted on February 18 2026).

Create your alert
to follow the executive moves at Bristol-Myers Squibb.